Medprin Regenerative Medical Technologies Co Ltd Sustainability Reports
The company specializes in the research, development, and manufacturing of high-performance implantable medical devices and human tissue regenerative materials. Its products include biomimetic synthetic dura mater patches, absorbable regenerated cellulose hemostats, and cranial maxillofacial repair systems.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG00W043XC1
1 reports from 2024 to 2024
